Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy Claudia MaletzkiMichael LinnebacherUwe Hobohm Opinion Paper 06 July 2013 Pages: 1283 - 1292
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients Michael A. MorseArvind ChaudhryH. Kim Lyerly Original Article 30 April 2013 Pages: 1293 - 1301
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the Hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival Richard K. YangNicholas A. KalogriopoulosPaul M. Sondel Original Article 10 May 2013 Pages: 1303 - 1313
The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells Stefanie TrojandtDiana KniesMatthias Bros Original article 11 May 2013 Pages: 1315 - 1326
A case of spontaneous systemic immunity to melanoma associated with cure after amputation for extensive regional recurrence Joshua M. JudgeLouis B. Brill IICraig L. Slingluff Jr. Original Article 12 May 2013 Pages: 1327 - 1334
Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK Carol InatsukaYi YangHailing Lu Original Article 18 May 2013 Pages: 1335 - 1345
TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells Ryan M. StephensonChwee Ming LimRobert L. Ferris Original Article 18 May 2013 Pages: 1347 - 1357
A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells Dhifaf SarhanErik WennerbergAndreas Lundqvist Original Article 21 May 2013 Pages: 1359 - 1368
Evaluating combinations of costimulatory antibody–ligand fusion proteins for targeted cancer immunotherapy Nora HornigKatharina ReinhardtDafne Müller Original Article 30 May 2013 Pages: 1369 - 1380
Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients Willemijn HoboLeonie StrobbeHarry Dolstra Original Article 02 June 2013 Pages: 1381 - 1392
Avidity of onconeural antibodies is of clinical relevance Cecilie TotlandMing YingChristian Vedeler Original Article 04 June 2013 Pages: 1393 - 1396
Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies Girja S. ShuklaDavid N. KragThomas A. Roland Original Article 05 June 2013 Pages: 1397 - 1410
Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours Agnieszka SzalaSambor SawickiMaciej Cedzynski Original Article Open access 07 June 2013 Pages: 1411 - 1419
Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis Fumitaka AriharaEishiro MizukoshiShuichi Kaneko Original Article 14 June 2013 Pages: 1421 - 1430
The Twelfth International Conference on Progress in Vaccination Against Cancer (PIVAC 12), Nottingham, UK, 11–13 September 2012: insights into the dynamics of anti-tumour immunity and the development of cancer vaccines Sumanjeet Kaur MalhiJaimy SaifJayakumar Narayanan Vadakekolathu Meeting Report 14 June 2013 Pages: 1431 - 1437